GOLDMAN SACHS GROUP INC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 70 filers reported holding APREA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$54,000
-20.6%
29,109
+22.2%
0.00%
Q4 2021$68,000
-90.8%
23,824
-83.5%
0.00%
Q3 2021$740,000
+142.6%
144,758
+131.4%
0.00%
Q2 2021$305,000
-18.2%
62,546
-14.4%
0.00%
Q1 2021$373,000
-53.1%
73,107
+121.1%
0.00%
Q3 2020$795,000
-24.0%
33,059
+22.6%
0.00%
Q2 2020$1,046,000
+149.0%
26,972
+123.2%
0.00%
Q1 2020$420,00012,0860.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders